Cephalon [clinicaltrials_resource:395eeae37599a2c044fede4d781aa919]
John Messina [clinicaltrials_resource:08846f25b04e8f060a9145c84ad5d4c2]Sr. Director, Clinical Pharmacology and Experimental Medicine, MD [clinicaltrials_resource:14a0eee7375bc8720269ca0a46013f11]Charles Brown, MD [clinicaltrials_resource:14d7f358e20cc16f3a1caa2652127705]Sponsor's Medical Director, MD [clinicaltrials_resource:2418b6269dce2fa08b2ab0ac9c477596]Sponsor's Medical Expert, Senior Director - Worldwide Clinical Research, MD [clinicaltrials_resource:289a9ae4f2161e6b709fa49062a371d9]Medical Department [clinicaltrials_resource:2c517f46d395349cf07ab2abace236de]Peter Brown [clinicaltrials_resource:3921206cc3cc728aec0c453033cc27b0]Sponsor's Medical Expert, Associate Director, Clinical Research, MD, PhD [clinicaltrials_resource:46794fd167724f85ec3a36c4abcbe927]Sponsor's Medical Expert - Sr. Director, Clinical Pharmacology [clinicaltrials_resource:4e248c0d6c967bcb194c7bf67849a50b]John Messina, Pharm D [clinicaltrials_resource:6fd39fe90d768bc14980a1bbb741e893]Sponsor's Medical Expert, Medical Director - Clinical Research Oncology [clinicaltrials_resource:890543482bc7014a920911892433029c]Gwendolyn Neibler, DO [clinicaltrials_resource:960a6e1aa8a7f6fbaae905e7117c6ff5]Sponsor's Medical Expert, Senior Director - Worldwide Clinical Research [clinicaltrials_resource:b43a07ac3f2b74b3d8fe5b62889cab19]Sponsor's Medical Expert [clinicaltrials_resource:be264b9c1092ec0636bc527516559f26]Sponsor's Medical Expert, MD [clinicaltrials_resource:ecf997f272c824af9bbf51dfc4d5eb00]
affiliation [clinicaltrials_vocabulary:affiliation]
collaborator [clinicaltrials_vocabulary:collaborator]
Open Study of CEP-701 in Patients With Refractory Acute Myeloid Leukemia With FLT-3 Mutation [clinicaltrials:NCT00030186]Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease [clinicaltrials:NCT00040404]Safety and Activity of SDX-105 (Bendamustine) in Patients With Rituximab Refractory Non-Hodgkin's Lymphoma [clinicaltrials:NCT00069758]SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL) [clinicaltrials:NCT00076349]Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder [clinicaltrials:NCT00078312]Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome(OSAHS) [clinicaltrials:NCT00078325]Safety and Efficacy Study of Armodafinil (CEP-10953) in the Treatment of Excessive Sleepiness Associated With Narcolepsy [clinicaltrials:NCT00078377]Study of CEP-701 in Patients With Acute Myeloid Leukemia (AML) [clinicaltrials:NCT00079482]Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea (OSA/H) Syndrome [clinicaltrials:NCT00079677]Safety/Efficacy Study With Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Chronic SWSD [clinicaltrials:NCT00080288]Study of CEP-701 in Treatment of Prostate Cancer [clinicaltrials:NCT00081601]Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients [clinicaltrials:NCT00105287]OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients [clinicaltrials:NCT00105937]Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy [clinicaltrials:NCT00107796]Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome [clinicaltrials:NCT00107809]PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome [clinicaltrials:NCT00107848]Safety and Efficacy of Treanda™ (Bendamustine HCl) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Are Refractory to Rituximab [clinicaltrials:NCT00139841]Safety and Efficacy of SDX-101 (R-Etodolac) in Combination With Chlorambucil, and That of Chlorambucil Alone, in Patients With Chronic Lymphocytic Leukemia (CLL) [clinicaltrials:NCT00151736]Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough Pain [clinicaltrials:NCT00214942]Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain [clinicaltrials:NCT00214955]Assess the Safety and Effectiveness of PROVIGIL Treatment in Children and Adolescents With Excessive Sleepiness [clinicaltrials:NCT00214968]Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHD [clinicaltrials:NCT00214981]Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults With Generalized Anxiety Disorder. [clinicaltrials:NCT00214994]Study to Assess Satisfaction With Modafinil Treatment in Children and Adolescents With ADHD [clinicaltrials:NCT00228540]Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness [clinicaltrials:NCT00228553]Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome [clinicaltrials:NCT00228566]Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain [clinicaltrials:NCT00228605]Evaluate the Safety of GABITRIL in Adults With Generalized Anxiety Disorder [clinicaltrials:NCT00233675]A 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder [clinicaltrials:NCT00236015]Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP) [clinicaltrials:NCT00236041]A 10-Week Efficacy and Safety Study for of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder [clinicaltrials:NCT00236054]A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder [clinicaltrials:NCT00236067]clinicaltrials:NCT00236080Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain [clinicaltrials:NCT00236093]Study of the Efficacy, Safety and Tolerability of Oral CEP-701 in Patients With Severe Psoriasis [clinicaltrials:NCT00236119]Evaluate the Efficacy and Safety of ACTIQ in Patients With Cancer and Breakthrough Pain [clinicaltrials:NCT00236145]Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma [clinicaltrials:NCT00242827]Safety and Efficacy of SDX-101 (R-Etodolac) in Patients With Relapsed or Refractory Multiple Myeloma (MM) [clinicaltrials:NCT00293111]Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHD [clinicaltrials:NCT00315276]Study to Evaluate the Efficacy and Safety of OraVescent Fentanyl Citrate Treatment for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Noncancer-Related Chronic Pain [clinicaltrials:NCT00343733]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
organization [clinicaltrials_vocabulary:organization]
Cephalon [clinicaltrials_resource:395eeae37599a2c044fede4d781aa919]
Bio2RDF identifier
395eeae37599a2c044fede4d781aa919
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:395eeae37599a2c044fede4d781aa919
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:395eeae37599a2c044fede4d781aa919
title
Cephalon
@en
type
label
Cephalon [clinicaltrials_resource:395eeae37599a2c044fede4d781aa919]
@en